DK258280A - Fremgangsmaade til fremstilling af oxymorfon - Google Patents
Fremgangsmaade til fremstilling af oxymorfonInfo
- Publication number
- DK258280A DK258280A DK258280A DK258280A DK258280A DK 258280 A DK258280 A DK 258280A DK 258280 A DK258280 A DK 258280A DK 258280 A DK258280 A DK 258280A DK 258280 A DK258280 A DK 258280A
- Authority
- DK
- Denmark
- Prior art keywords
- oxymorphone
- procedure
- manufacturing
- Prior art date
Links
- UQCNKQCJZOAFTQ-ISWURRPUSA-N Oxymorphone Chemical compound O([C@H]1C(CC[C@]23O)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O UQCNKQCJZOAFTQ-ISWURRPUSA-N 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 229960005118 oxymorphone Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
- C07D489/08—Oxygen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polarising Elements (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95305678A | 1978-10-19 | 1978-10-19 | |
| PCT/US1979/000862 WO1980000841A1 (en) | 1978-10-19 | 1979-10-18 | Process for producing oxymorphone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK258280A true DK258280A (da) | 1980-06-17 |
Family
ID=25493512
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK258280A DK258280A (da) | 1978-10-19 | 1980-06-17 | Fremgangsmaade til fremstilling af oxymorfon |
Country Status (16)
| Country | Link |
|---|---|
| JP (1) | JPS55501025A (da) |
| AU (1) | AU5189779A (da) |
| BE (1) | BE879494A (da) |
| CA (1) | CA1108132A (da) |
| CS (1) | CS211364B2 (da) |
| DK (1) | DK258280A (da) |
| ES (1) | ES485154A1 (da) |
| FI (1) | FI793235A7 (da) |
| FR (1) | FR2439201A1 (da) |
| GB (1) | GB2049680A (da) |
| IL (1) | IL58489A0 (da) |
| IT (1) | IT7969032A0 (da) |
| NL (1) | NL7920126A (da) |
| NO (1) | NO793297L (da) |
| SE (1) | SE8004454L (da) |
| WO (1) | WO1980000841A1 (da) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4795813A (en) * | 1981-08-17 | 1989-01-03 | The Florida Board Of Regents On Behalf Of The Florida State University | Synthesis of derivatives of codeine and other 3-O-alkylmorphines |
| US5668285A (en) * | 1986-10-31 | 1997-09-16 | The United States Of America As Represented By The Department Of Health And Human Services | Total synthesis of northebaine, normophine, noroxymorphone enantiomers and derivatives via N-Nor intermediates |
| FR2636330B1 (fr) * | 1988-09-13 | 1990-11-30 | Sanofi Sa | Procede de preparation de derives de morphinane |
| AU642447B2 (en) * | 1989-10-16 | 1993-10-21 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | Total synthesis of northebaine, normorphine, noroxymorphone enantiomers and derivatives via N-nor intermediates |
| US8329216B2 (en) | 2001-07-06 | 2012-12-11 | Endo Pharmaceuticals Inc. | Oxymorphone controlled release formulations |
| EP1404333A1 (en) | 2001-07-06 | 2004-04-07 | Endo Pharmaceuticals Inc. | Oxymorphone controlled release formulations |
| WO2003004033A1 (en) | 2001-07-06 | 2003-01-16 | Penwest Pharmaceuticals Company | Sustained release formulations of oxymorphone |
| US7776314B2 (en) | 2002-06-17 | 2010-08-17 | Grunenthal Gmbh | Abuse-proofed dosage system |
| DE10361596A1 (de) | 2003-12-24 | 2005-09-29 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
| US20070048228A1 (en) | 2003-08-06 | 2007-03-01 | Elisabeth Arkenau-Maric | Abuse-proofed dosage form |
| DE10336400A1 (de) | 2003-08-06 | 2005-03-24 | Grünenthal GmbH | Gegen Missbrauch gesicherte Darreichungsform |
| DE102005005446A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Bruchfeste Darreichungsformen mit retardierter Freisetzung |
| DE102004032049A1 (de) | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Gegen Missbrauch gesicherte, orale Darreichungsform |
| DE102005005449A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
| CN101395159A (zh) | 2006-03-02 | 2009-03-25 | 马林克罗特公司 | 制备含有低含量α,β-不饱和酮化合物的吗啡烷-6-酮产物的方法 |
| JP5774853B2 (ja) | 2008-01-25 | 2015-09-09 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 医薬投薬形 |
| MX2010012039A (es) | 2008-05-09 | 2010-11-30 | Gruenenthal Gmbh | Proceso para la preparacion de una formulacion de polvo intermedia y una forma de dosificacion solida final bajo el uso de un paso de congelacion por rocio. |
| BR112012001547A2 (pt) | 2009-07-22 | 2016-03-08 | Gruenenthal Gmbh | forma de dosagem farmacêutica extrusada por fusão a quente |
| ES2428938T3 (es) | 2009-07-22 | 2013-11-12 | Grünenthal GmbH | Forma de dosificación resistente a la manipulación y estabilizada frente a la oxidación |
| CN103179954A (zh) | 2010-09-02 | 2013-06-26 | 格吕伦塔尔有限公司 | 包含阴离子聚合物的抗破碎剂型 |
| CA2808219C (en) | 2010-09-02 | 2019-05-14 | Gruenenthal Gmbh | Tamper resistant dosage form comprising inorganic salt |
| PL2736497T3 (pl) | 2011-07-29 | 2018-01-31 | Gruenenthal Gmbh | Tabletka odporna na ingerencję, zapewniająca natychmiastowe uwalnianie leku |
| CA2839123A1 (en) | 2011-07-29 | 2013-02-07 | Grunenthal Gmbh | Tamper-resistant tablet providing immediate drug release |
| MX356421B (es) | 2012-02-28 | 2018-05-29 | Gruenenthal Gmbh | Forma de dosificacion resistente a la manipulacion indebida que comprende un compuesto farmacologicamente activo y un polimero anionico. |
| PL2838512T3 (pl) | 2012-04-18 | 2018-12-31 | Grünenthal GmbH | Farmaceutyczna postać dawkowania odporna na niewłaściwe użycie i odporna na uderzeniowe uwalnianie dawki |
| US10064945B2 (en) | 2012-05-11 | 2018-09-04 | Gruenenthal Gmbh | Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc |
| MX371432B (es) | 2013-05-29 | 2020-01-30 | Gruenenthal Gmbh | Forma de dosificacion resistente al uso indebido que contiene una o mas particulas. |
| WO2014191396A1 (en) | 2013-05-29 | 2014-12-04 | Grünenthal GmbH | Tamper resistant dosage form with bimodal release profile |
| US10624862B2 (en) | 2013-07-12 | 2020-04-21 | Grünenthal GmbH | Tamper-resistant dosage form containing ethylene-vinyl acetate polymer |
| WO2015078891A1 (en) | 2013-11-26 | 2015-06-04 | Farmaceutici Formenti S.P.A. | Preparation of a powdery pharmaceutical composition by means of cryo-milling |
| US20150320690A1 (en) | 2014-05-12 | 2015-11-12 | Grünenthal GmbH | Tamper resistant immediate release capsule formulation comprising tapentadol |
| EP3148512A1 (en) | 2014-05-26 | 2017-04-05 | Grünenthal GmbH | Multiparticles safeguarded against ethanolic dose-dumping |
| BR112017021475A2 (pt) | 2015-04-24 | 2018-07-10 | Gruenenthal Gmbh | forma de dosagem resistente à adulteração (tamper) com liberação imediata e resistência contra extração de solvente |
| AU2016319203A1 (en) | 2015-09-10 | 2018-02-22 | Grünenthal GmbH | Protecting oral overdose with abuse deterrent immediate release formulations |
| ES2701855T3 (es) | 2016-05-31 | 2019-02-26 | Alcaliber Investig Desarrollo E Innovacion Slu | Proceso para la obtención de 3,14-diacetiloximorfona a partir de oripavina |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3249616A (en) * | 1966-05-03 | Ix-dfflydroxy-g-oxo-n-phenethylmor- phinan (cis) and production thereof | ||
| US2806033A (en) * | 1955-08-03 | 1957-09-10 | Lewenstein | Morphine derivative |
| US3775414A (en) * | 1972-05-10 | 1973-11-27 | Bristol Myers Co | Process for the preparation of 14-hydroxymorphinan derivatives |
-
1979
- 1979-10-12 NO NO793297A patent/NO793297L/no unknown
- 1979-10-18 CA CA337,908A patent/CA1108132A/en not_active Expired
- 1979-10-18 FR FR7925895A patent/FR2439201A1/fr not_active Withdrawn
- 1979-10-18 FI FI793235A patent/FI793235A7/fi not_active Application Discontinuation
- 1979-10-18 AU AU51897/79A patent/AU5189779A/en not_active Abandoned
- 1979-10-18 JP JP50190279A patent/JPS55501025A/ja active Pending
- 1979-10-18 ES ES485154A patent/ES485154A1/es not_active Expired
- 1979-10-18 WO PCT/US1979/000862 patent/WO1980000841A1/en not_active Ceased
- 1979-10-18 BE BE0/197710A patent/BE879494A/fr unknown
- 1979-10-18 IT IT7969032A patent/IT7969032A0/it unknown
- 1979-10-18 NL NL7920126A patent/NL7920126A/nl unknown
- 1979-10-18 GB GB8014422A patent/GB2049680A/en not_active Withdrawn
- 1979-10-18 IL IL58489A patent/IL58489A0/xx unknown
- 1979-10-19 CS CS797115A patent/CS211364B2/cs unknown
-
1980
- 1980-06-16 SE SE8004454A patent/SE8004454L/xx not_active Application Discontinuation
- 1980-06-17 DK DK258280A patent/DK258280A/da unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR2439201A1 (fr) | 1980-05-16 |
| IL58489A0 (en) | 1980-01-31 |
| CS211364B2 (en) | 1982-02-26 |
| SE8004454L (sv) | 1980-06-16 |
| JPS55501025A (da) | 1980-11-27 |
| ES485154A1 (es) | 1980-06-16 |
| CA1108132A (en) | 1981-09-01 |
| WO1980000841A1 (en) | 1980-05-01 |
| IT7969032A0 (it) | 1979-10-18 |
| NO793297L (no) | 1980-04-22 |
| BE879494A (fr) | 1980-02-15 |
| GB2049680A (en) | 1980-12-31 |
| NL7920126A (nl) | 1980-08-29 |
| AU5189779A (en) | 1980-04-24 |
| FI793235A7 (fi) | 1981-01-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK258280A (da) | Fremgangsmaade til fremstilling af oxymorfon | |
| DK325079A (da) | Fremgangsmaade til fremstilling af tiazolidinderivater | |
| DK365079A (da) | Fremgangsmaade til fremstilling af 1-alfa-hydroxylerede calciferoler | |
| DK156779A (da) | Fremgangsmaade til fremstilling af cycloalkyltriazoler | |
| DK129879A (da) | Fremgangsmaade til fremstilling af n-heterocyclyl-4-piperidinaminer | |
| DK37879A (da) | Fremgangsmaade til fremstilling af oligoimider | |
| DK68179A (da) | Fremgangsmaade til fremstilling af 9-aminodibenzoepyraner | |
| DK268579A (da) | Fremgangsmaade til fremstilling af phenetamolaminer | |
| DK380579A (da) | Fremgangsmaade til fremstilling af formlegemer af ekspanderet formstof | |
| DK77479A (da) | Fremgangsmaade til fremstilling af penicilliner | |
| DK150984C (da) | Fremgangsmaade til kontinuerlig fremstilling af azopigmenter | |
| DK307279A (da) | Fremgangsmaade til fremstilling af phenolethere | |
| DK480679A (da) | Fremgangsmaade til fremstilling af cephalosporinforbindelser | |
| DK148259C (da) | Fremgangsmaade til fremstilling af lysergolderivater | |
| DK265779A (da) | Fremgangsmaade til fremstilling af o-methallyloxyphenol | |
| DK69479A (da) | Fremgangsmaade til fremstilling af 2-phenylimino-imidazolidiner | |
| DK452679A (da) | Fremgangsmaade til fremstilling af cephalosporinforbindelser | |
| DK433779A (da) | Fremgangsmaade til fremstilling af phenylquinolizidiner | |
| DK382579A (da) | Fremgangsmaade til fremstilling af auronderivater | |
| DK150471C (da) | Fremgangsmaade til fremstilling af trifluormethylphenoler | |
| DK543079A (da) | Fremgangsmaade til fremstilling af benzaldehyder | |
| DK58579A (da) | Fremgangsmaade til fremstilling af hydroxyphenylethere | |
| DK424279A (da) | Fremgangsmaade til fremstilling af formlegemer | |
| DK77179A (da) | Fremgangsmaade til fremstilling af androstadiener | |
| DK145179A (da) | Fremgangsmaade til fremstilling af 4-methyl-5-hydroxymethyl-imidazol |